Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder
Author:
Affiliation:
1. Pear Therapeutics, Inc., Boston, MA, USA
2. Fralin Biomedical Research Institute at VTC, Roanoke, VA, USA
3. Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA
4. Provonix, Sewell, NJ, USA
Funder
National Institute on Drug Abuse
Wilbur Mills Endowment
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1846022
Reference35 articles.
1. Substance Abuse and Mental Health Services Administration. 2019 National Survey of Drug Use and Health (NSDUH) releases [cited 2020 Sep 29]. Available from: https://www.samhsa.gov/data/release/2019-national-survey-drug-use-and-health-nsduh-releases.
2. Centers for Disease Control and Prevention. Wide-ranging online data for epidemiological research (WONDER). National Center on Health Statistics, Center for Disease Control and Prevention [Published 2018. cited 2019 Jul 29]. https://wonder.cdc.gov.
3. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
4. Center for Behavioral Health Statistics and Quality. 2017 National survey on drug use and health final analytic file codebook. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2018.
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prescription Digital Therapeutics for Substance Use Disorder in Primary Care: Mixed Methods Evaluation of a Pilot Implementation Study;JMIR Formative Research;2024-09-02
2. Redesigning Pharmacy to Improve Public Health Outcomes: Expanding Retail Spaces for Digital Therapeutics to Replace Consumer Products That Increase Mortality and Morbidity Risks;Pharmacy;2024-07-12
3. Examining health apps and wearable use in improving physical and mental well-being across U.S., China, and Singapore;Scientific Reports;2024-05-11
4. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09
5. Prescription Digital Therapeutics for Substance Use Disorder in Primary Care: Mixed Methods Evaluation of a Pilot Implementation Study (Preprint);2024-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3